- Home
- PODC vs KZR Comparison
PODC vs KZR Comparison
Compare PODC & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$6.32
Company Overview
Basic Information| Metric | PODC | KZR |
|---|---|---|
| Founded | 2013 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.5M | 45.8M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | PODC | KZR |
|---|---|---|
| Price | $2.09 | $6.32 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | ★ 35.8K | 30.4K |
| Earning Date | 02-11-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $56,957,000.00 | N/A |
| Revenue This Year | $17.39 | N/A |
| Revenue Next Year | $19.94 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 20.01 | N/A |
| 52 Week Low | $1.28 | $3.53 |
| 52 Week High | $2.94 | $6.95 |
Technical Indicators
Market Signals| Indicator | PODC | KZR |
|---|---|---|
| Relative Strength Index (RSI) | 45.01 | 59.91 |
| Support Level | $1.97 | $6.22 |
| Resistance Level | $2.35 | $6.37 |
| Average True Range (ATR) | 0.15 | 0.10 |
| MACD | -0.03 | -0.02 |
| Stochastic Oscillator | 24.80 | 72.73 |
Price Performance
Historical Comparison PODC
KZR
About PODC PodcastOne Inc.
PodcastOne Inc is a podcast platform and publisher that makes its content available to audiences via all podcasting distribution platforms, including its website, its PodcastOne app, Apple Podcasts, Spotify, Amazon Music, and more.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.